103 related articles for article (PubMed ID: 18360710)
1. Potentiation of cytotoxicity by combination of imatinib and chlorimipramine in glioma.
Bilir A; Erguven M; Oktem G; Ozdemir A; Uslu A; Aktas E; Bonavida B
Int J Oncol; 2008 Apr; 32(4):829-39. PubMed ID: 18360710
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of imatinib and synergism of combination treatment with chemotherapeutic agents in malignant glioma cells.
Ren H; Tan X; Dong Y; Giese A; Chou TC; Rainov N; Yang B
Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):241-52. PubMed ID: 19159435
[TBL] [Abstract][Full Text] [Related]
3. Carvedilol in glioma treatment alone and with imatinib in vitro.
Erguven M; Yazihan N; Aktas E; Sabanci A; Li CJ; Oktem G; Bilir A
Int J Oncol; 2010 Apr; 36(4):857-66. PubMed ID: 20198329
[TBL] [Abstract][Full Text] [Related]
4. [Effect of imatinib at different concentrations on rat C6 glioma cell apoptosis and cell cycle].
Yang L; Xu ZY; Chen XH; Wang KW; Li GF; Chen ZL
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1089-91. PubMed ID: 20501402
[TBL] [Abstract][Full Text] [Related]
5. The inhibitory effect of suramin on telomerase activity and spheroid growth of C6 glioma cells.
Erguven M; Akev N; Ozdemir A; Karabulut E; Bilir A
Med Sci Monit; 2008 Aug; 14(8):BR165-73. PubMed ID: 18667993
[TBL] [Abstract][Full Text] [Related]
6. Characterization of an imatinib-sensitive subset of high-grade human glioma cultures.
Hägerstrand D; Hesselager G; Achterberg S; Wickenberg Bolin U; Kowanetz M; Kastemar M; Heldin CH; Isaksson A; Nistér M; Ostman A
Oncogene; 2006 Aug; 25(35):4913-22. PubMed ID: 16547494
[TBL] [Abstract][Full Text] [Related]
7. Combination of imatinib and vinorelbine enhances cell growth inhibition in breast cancer cells via PDGFR beta signalling.
Weigel MT; Meinhold-Heerlein I; Bauerschlag DO; Schem C; Bauer M; Jonat W; Maass N; Mundhenke C
Cancer Lett; 2009 Jan; 273(1):70-9. PubMed ID: 18809244
[TBL] [Abstract][Full Text] [Related]
8. Local delivery of poly lactic-co-glycolic acid microspheres containing imatinib mesylate inhibits intracranial xenograft glioma growth.
Benny O; Menon LG; Ariel G; Goren E; Kim SK; Stewman C; Black PM; Carroll RS; Machluf M
Clin Cancer Res; 2009 Feb; 15(4):1222-31. PubMed ID: 19190128
[TBL] [Abstract][Full Text] [Related]
9. N-acetyl cysteine enhances imatinib-induced apoptosis of Bcr-Abl+ cells by endothelial nitric oxide synthase-mediated production of nitric oxide.
Rakshit S; Bagchi J; Mandal L; Paul K; Ganguly D; Bhattacharjee S; Ghosh M; Biswas N; Chaudhuri U; Bandyopadhyay S
Apoptosis; 2009 Mar; 14(3):298-308. PubMed ID: 19153832
[TBL] [Abstract][Full Text] [Related]
10. TNF-alpha- and TRAIL-resistant glioma cells undergo autophagy-dependent cell death induced by activated microglia.
Mora R; Abschuetz A; Kees T; Dokic I; Joschko N; Kleber S; Geibig R; Mosconi E; Zentgraf H; Martin-Villalba A; Régnier-Vigouroux A
Glia; 2009 Apr; 57(5):561-81. PubMed ID: 18942750
[TBL] [Abstract][Full Text] [Related]
11. Chlorimipramine: a novel anticancer agent with a mitochondrial target.
Daley E; Wilkie D; Loesch A; Hargreaves IP; Kendall DA; Pilkington GJ; Bates TE
Biochem Biophys Res Commun; 2005 Mar; 328(2):623-32. PubMed ID: 15694394
[TBL] [Abstract][Full Text] [Related]
12. Medroxyprogesterone acetate induces c6 glioma chemosensitization via antidepressant-like lysosomal phospholipidosis/myelinosis in vitro.
Altinoz MA; Gedikoglu G; Sav A; Ozcan E; Ozdilli K; Bilir A; Del Maestro RF
Int J Neurosci; 2007 Oct; 117(10):1465-80. PubMed ID: 17729157
[TBL] [Abstract][Full Text] [Related]
13. Imatinib targeting of KIT-mutant oncoprotein in melanoma.
Jiang X; Zhou J; Yuen NK; Corless CL; Heinrich MC; Fletcher JA; Demetri GD; Widlund HR; Fisher DE; Hodi FS
Clin Cancer Res; 2008 Dec; 14(23):7726-32. PubMed ID: 19047099
[TBL] [Abstract][Full Text] [Related]
14. Effects of the histone deacetylase inhibitor valproic acid on the sensitivity of anaplastic thyroid cancer cell lines to imatinib.
Catalano MG; Pugliese M; Poli R; Bosco O; Bertieri R; Fortunati N; Boccuzzi G
Oncol Rep; 2009 Feb; 21(2):515-21. PubMed ID: 19148530
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of autophagy at a late stage enhances imatinib-induced cytotoxicity in human malignant glioma cells.
Shingu T; Fujiwara K; Bögler O; Akiyama Y; Moritake K; Shinojima N; Tamada Y; Yokoyama T; Kondo S
Int J Cancer; 2009 Mar; 124(5):1060-71. PubMed ID: 19048625
[TBL] [Abstract][Full Text] [Related]
16. Patupilone (epothilone B, EPO906) and imatinib (STI571, Glivec) in combination display enhanced antitumour activity in vivo against experimental rat C6 glioma.
O'Reilly T; Wartmann M; Maira SM; Hattenberger M; Vaxelaire J; Muller M; Ferretti S; Buchdunger E; Altmann KH; McSheehy PMJ
Cancer Chemother Pharmacol; 2005 Apr; 55(4):307-317. PubMed ID: 15723258
[TBL] [Abstract][Full Text] [Related]
17. STI571 and morpholine derivative of doxorubicin collaborate in inhibition of K562 cell proliferation by inducing differentiation and mitochondrial pathway of apoptosis.
Jakubowska J; Wasowska-Lukawska M; Czyz M
Eur J Pharmacol; 2008 Oct; 596(1-3):41-9. PubMed ID: 18782571
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide donors attenuate clongenic potential in rat C6 glioma cells treated with alkylating chemotherapeutic agents.
Yang JJ; Yin JH; Yang DI
Neurosci Lett; 2007 May; 418(1):106-10. PubMed ID: 17412510
[TBL] [Abstract][Full Text] [Related]
19. Compound 48, a novel dual PPAR alpha/gamma ligand, inhibits the growth of human CML cell lines and enhances the anticancer-effects of imatinib.
Bertz J; Zang C; Liu H; Wächter M; Possinger K; Koeffler HP; Elstner E
Leuk Res; 2009 May; 33(5):686-92. PubMed ID: 19131110
[TBL] [Abstract][Full Text] [Related]
20. Tetraethylammonium inhibits glioma cells via increasing production of intracellular reactive oxygen species.
Yang KB; Zhao SG; Liu YH; Hu EX; Liu BX
Chemotherapy; 2009; 55(5):372-80. PubMed ID: 19707016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
